Pharma Leaders FDA Approves Bavarian Nordic’s Chikungunya Vaccine Vimkunya 1 year agoby David Miller951 Views Vimkunya is the first FDA-approved vaccine for chikungunya in patients over 12 years of age. Vimkunya is the first FDA-approved vaccine for chikungunya in patients over 12 years of age.